Concepedia

Yoichi Takakusagi

YT

Statistics

Publications

41

Citations

1.2K

H-Index

23

Active since

2005

Affiliations

Tokyo University of Science(Current)

The University of Tokyo

National Institutes for Quantum Science and Technology

Kyushu University

Center for Cancer Research

Yoichi Takakusagi is an author at Tokyo University of Science specializing in medicine, biochemistry, and molecular biology.

Publications per year

2005–2024

41

Publications

41

Lariatins, Novel Anti-mycobacterial Peptides with a Lasso Structure, Produced by Rhodococcus jostii K01-B0171

Masato Iwatsuki, Ryuji Uchida, Yoichi Takakusagi et al. · The Journal of Antibiotics · 2007 · 89 citations

Life Sciences, Biotechnology, Microbiology +16

Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302

Jonathan W. Wojtkowiak, Heather C Cornnell, Shingo Matsumoto et al. · Cancer & Metabolism · 2015 · 81 citations · Full text

Medicine, Oncology, Pharmacology +17

13C-MR Spectroscopic Imaging with Hyperpolarized [1-13C]pyruvate Detects Early Response to Radiotherapy in SCC Tumors and HT-29 Tumors

Keita Saito, Shingo Matsumoto, Yoichi Takakusagi et al. · Clinical Cancer Research · 2015 · 61 citations · Full text

Medicine, Oncology, Radiology +16

Hyperpolarized [1-13C]-Pyruvate Magnetic Resonance Spectroscopic Imaging of Prostate Cancer <i>In Vivo</i> Predicts Efficacy of Targeting the Warburg Effect

Bradley T. Scroggins, Masayuki Matsuo, Ayla O. White et al. · Clinical Cancer Research · 2018 · 50 citations · Full text

Medicine, Biochemistry, Oncology +17

Metabolic and Physiologic Imaging Biomarkers of the Tumor Microenvironment Predict Treatment Outcome with Radiation or a Hypoxia-Activated Prodrug in Mice

Shingo Matsumoto, Shun Kishimoto, Keita Saito et al. · Cancer Research · 2018 · 49 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 41